William Slater, M.D.'s major clinical research interests are coronary artery disease, arrhythmia and evaluating novel antiarrhythmic agents. He is board certified in cardiac electrophysiology.

Dr. Slater's prior experience includes evaluation of a novel anti-oxidant in preventing cardiomyopathy. His current clinical trials include evaluation of a novel therapeutic in conversion of atrial fibrillation and a study of a therapeutic in treating diabetic cardiomyopathy.